Medifast, Inc. (MED)
| Market Cap | 2.86B |
| Revenue (ttm) | 934.84M |
| Net Income (ttm) | 102.86M |
| Shares Out | 11.77M |
| EPS (ttm) | 8.68 |
| PE Ratio | 27.03 |
| Forward PE | n/a |
| Dividend | $4.52 |
| Dividend Yield | 1.93% |
| Trading Day | March 8 |
| Last Price | $234.63 |
| Previous Close | $243.16 |
| Change ($) | -8.53 |
| Change (%) | -3.51% |
| Day's Open | 243.31 |
| Day's Range | 231.95 - 246.87 |
| Day's Volume | 125,598 |
| 52-Week Range | 47.19 - 279.46 |
Medifast (MED) could produce exceptional returns because of its solid growth attributes.
Medifast's (MED) fourth-quarter 2020 results reflect strong earnings and sales growth. Robust OPTAVIA performance, courtesy of a rise in active earning coaches, fueled results.
Medifast's (MED) fourth-quarter 2020 results are likely to reflect strength in OPTAVIA, thanks to consumers' growing inclination toward health and wellness.
Although retailers have been struggling, grocery stocks like Target Corporation (TGT) and The Hain Celestial Group, Inc. (HAIN) have been benefiting since the coronavirus outbreak.
Rotation Continues But Gains Pared On Capitol Protest: Target, Medifast, General Motors In Focus
Rotation Continues But Gains Pared On Capitol Protest. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market...
Several food companies are gaining on higher at-home consumption amid the pandemic. Also, focus on innovation and other brand-building efforts has been backing growth for B&G Foods (BGS), Hain...
According to the All-in-one Screener, a Premium feature of GuruFocus, five stocks with high financial strength and good dividend yields that have outperformed the Standard & Poor's 500 Index i...
Investing in stocks which have outpaced the market in 2020, defying the impacts of the COVID-19 outbreak, and have the potential for greater returns in 2021 is advisable.
BALTIMORE, Dec. 29, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Ch...
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Medifast (MED) has been benefiting from strength in OPTAVIA along with a focus on core growth strategies even amid the pandemic.
BALTIMORE, Dec. 14, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced that Non- Executi...
BALTIMORE, Dec. 10, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that its Board of ...
Joel Greenblatt (Trades, Portfolio) introduced the investing world to the "Magic Formula" when he published his 2005 book, "The Little Book That Beats the Market." The idea behind the Magic Fo...
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Growth names have been at the forefront of this new COVID world, and have kept society not only afloat, but growing and transitioning to this new normal. Nobody knows exactly what the future w...
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Medifast (MED) has been gaining on robust performance of OPTAVIA. Also, the company has certain planned investments for growth, though they are likely to affect margins.
The functional foods market saw sales top $267 billion in February of this year on a global basis, with sales in the US reaching $63 billion, according to Euromonitor 2020.
Healthy Living Stocks for the Win (NASDAQ: WW) (NYSE: PLNT) (OTC: SBEV) (NYSE: MED)
Medifast's (MED) third-quarter 2020 results reflect increased earnings and sales. Robust OPTAVIA performance, courtesy of rise in active earning coaches, fuels results.
Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Earnings Call Transcript
Medifast (MED) delivered earnings and revenue surprises of 16.87% and 10.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Medifast, Inc. (MED) CEO Dan Chard on Q3 2020 Results - Quick Version Earnings Call Transcript
BALTIMORE, Nov. 2, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest growing health and wellness communities, OPTAVIA®, which offers Lifelong Transformatio...
The large amount of overweight adults in the United States and other regions provides a significant market for Medifast's growth. Medifast has positive revenue and earnings growth momentum tha...
Medifast's (MED) third-quarter results are likely to reflect gains from consumers' increased inclination toward health products amid the pandemic. However, high costs are a concern.
BALTIMORE, Oct. 20, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results fo...
Medifast's (MED) OPTAVIA lifestyle solution bodes well amid evolving consumer interests in health and wellness. However, rising costs are a concern.
Medifast (MED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
According to the All-in-One Screener, a Premium feature of GuruFocus, five stalwarts that have high financial strength and expanding operating margins include Mastech Digital Inc. (MHH), Colum...
Here are five top-ranked liquid stocks, including Nu Skin Enterprises (NUS), that investors can snap up for enhancing portfolio returns.
Stocks with strong fundamentals and attractive valuations based on exclusive method
Here are four top-ranked liquid stocks, including Zumiez (ZUMZ), that investors can bank on for alluring returns.
Volatility may persist for a few more days. However, the worst of Wall Street is long over and the overall market movement should remain positive going forward.
Several stocks skyrocketed last week and a handful of these were Zacks top-ranked.
Is (MED) Outperforming Other Consumer Staples Stocks This Year?
Medifast CEO Dan Chard discusses why his company has been so successful
Health and wellness company Medifast shares are up by 220 percent since the March lows as people are taking a renewed interest in staying fit amid the pandemic. CEO of Medifast Dan Chard joins...
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.
Here are four excellent liquid stocks, including Logitech (LOGI), that can contribute to making an outstanding portfolio for investors.
It's a good time to invest in growth stocks, but it's a better idea to see that they have the financial strength to snap out of any difficult situation if it arises.
Here are four top-ranked liquid stocks, including Medifast (MED) that investors can add to their portfolio for fat returns.
With a current revenue of nearly $400 million, it is now clear the company will exceed its original revenue guidance.
Medifast's (MED) second-quarter 2020 results reflect solid earnings and sales. Strong OPTAVIA performance, thanks to a substantial rise in active earning coaches, boosted results.
Medifast, Inc. (MED) CEO Dan Chard on Q2 2020 Results - Earnings Call Transcript
Medifast (MED) delivered earnings and revenue surprises of 6.52% and 12.97%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Seven top-ranked companies are poised to beat on earnings today after the closing bell.
3 Dividend Stocks Killing It This Year (They Are Not Tech Stocks Or Gold)
About MED
Medifast, through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. It offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, and soups under the Medifast, OPTAVIA, Thrive by Medifast, Optimal Health by Take Shape for Life, and Flavors of Home brands. The company markets its products through point of sale... [Read more...]
| Industry Personal Services | Founded 1980 |
| CEO Daniel Chard | Employees 713 |
| Stock Exchange NYSE | Ticker Symbol MED |
Financial Performance
In 2020, Medifast's revenue was $934.84 million, an increase of 30.99% compared to the previous year's $713.67 million. Earnings were $102.86 million, an increase of 32.01%.
Analyst Forecasts
According to 3 analysts, the average rating for Medifast stock is "Strong Buy." The 12-month stock price forecast is 289.25, which is an increase of 23.28% from the latest price.